Cargando…

Comment On: Prospective Phase II Trials Validate the Effect of Neoadjuvant Chemotherapy on Pattern of Recurrence in Pancreatic Adenocarcinoma

Detalles Bibliográficos
Autores principales: Liu, Zhi-Peng, Dai, Hai-Su, Su, Xing-Xing, Yang, Yi-Shi, Yin, Xian-Yu, Chen, Zhi-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health, Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431567/
https://www.ncbi.nlm.nih.gov/pubmed/37601477
http://dx.doi.org/10.1097/AS9.0000000000000273
_version_ 1785091231771000832
author Liu, Zhi-Peng
Dai, Hai-Su
Su, Xing-Xing
Yang, Yi-Shi
Yin, Xian-Yu
Chen, Zhi-Yu
author_facet Liu, Zhi-Peng
Dai, Hai-Su
Su, Xing-Xing
Yang, Yi-Shi
Yin, Xian-Yu
Chen, Zhi-Yu
author_sort Liu, Zhi-Peng
collection PubMed
description
format Online
Article
Text
id pubmed-10431567
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Wolters Kluwer Health, Inc.
record_format MEDLINE/PubMed
spelling pubmed-104315672023-08-18 Comment On: Prospective Phase II Trials Validate the Effect of Neoadjuvant Chemotherapy on Pattern of Recurrence in Pancreatic Adenocarcinoma Liu, Zhi-Peng Dai, Hai-Su Su, Xing-Xing Yang, Yi-Shi Yin, Xian-Yu Chen, Zhi-Yu Ann Surg Open Letter to the Editor Wolters Kluwer Health, Inc. 2023-04-17 /pmc/articles/PMC10431567/ /pubmed/37601477 http://dx.doi.org/10.1097/AS9.0000000000000273 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Letter to the Editor
Liu, Zhi-Peng
Dai, Hai-Su
Su, Xing-Xing
Yang, Yi-Shi
Yin, Xian-Yu
Chen, Zhi-Yu
Comment On: Prospective Phase II Trials Validate the Effect of Neoadjuvant Chemotherapy on Pattern of Recurrence in Pancreatic Adenocarcinoma
title Comment On: Prospective Phase II Trials Validate the Effect of Neoadjuvant Chemotherapy on Pattern of Recurrence in Pancreatic Adenocarcinoma
title_full Comment On: Prospective Phase II Trials Validate the Effect of Neoadjuvant Chemotherapy on Pattern of Recurrence in Pancreatic Adenocarcinoma
title_fullStr Comment On: Prospective Phase II Trials Validate the Effect of Neoadjuvant Chemotherapy on Pattern of Recurrence in Pancreatic Adenocarcinoma
title_full_unstemmed Comment On: Prospective Phase II Trials Validate the Effect of Neoadjuvant Chemotherapy on Pattern of Recurrence in Pancreatic Adenocarcinoma
title_short Comment On: Prospective Phase II Trials Validate the Effect of Neoadjuvant Chemotherapy on Pattern of Recurrence in Pancreatic Adenocarcinoma
title_sort comment on: prospective phase ii trials validate the effect of neoadjuvant chemotherapy on pattern of recurrence in pancreatic adenocarcinoma
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431567/
https://www.ncbi.nlm.nih.gov/pubmed/37601477
http://dx.doi.org/10.1097/AS9.0000000000000273
work_keys_str_mv AT liuzhipeng commentonprospectivephaseiitrialsvalidatetheeffectofneoadjuvantchemotherapyonpatternofrecurrenceinpancreaticadenocarcinoma
AT daihaisu commentonprospectivephaseiitrialsvalidatetheeffectofneoadjuvantchemotherapyonpatternofrecurrenceinpancreaticadenocarcinoma
AT suxingxing commentonprospectivephaseiitrialsvalidatetheeffectofneoadjuvantchemotherapyonpatternofrecurrenceinpancreaticadenocarcinoma
AT yangyishi commentonprospectivephaseiitrialsvalidatetheeffectofneoadjuvantchemotherapyonpatternofrecurrenceinpancreaticadenocarcinoma
AT yinxianyu commentonprospectivephaseiitrialsvalidatetheeffectofneoadjuvantchemotherapyonpatternofrecurrenceinpancreaticadenocarcinoma
AT chenzhiyu commentonprospectivephaseiitrialsvalidatetheeffectofneoadjuvantchemotherapyonpatternofrecurrenceinpancreaticadenocarcinoma